Variant report

Variant	esv3370554
Chromosome Location	chr20:1165752-1167250
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr20:1166535-1166710	HepG2	liver:	n/a	n/a
2	ARID3A	chr20:1166469-1166713	K562	blood:	n/a	n/a
3	BACH1	chr20:1166477-1166774	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr20:1166473-1166846	K562	blood:	n/a	n/a
5	BRCA1	chr20:1166513-1166701	HepG2	liver:	n/a	n/a
6	CCNT2	chr20:1165384-1166670	K562	blood:	n/a	chr20:1166606-1166615 chr20:1165723-1165732 chr20:1166265-1166274
7	CEBPD	chr20:1166377-1166849	HepG2	liver:	n/a	n/a
8	CHD2	chr20:1167070-1167706	HepG2	liver:	n/a	n/a
9	CHD2	chr20:1166546-1166764	H1-hESC	embryonic stem cell:	n/a	n/a
10	CHD2	chr20:1166473-1166742	HepG2	liver:	n/a	n/a
11	CHD2	chr20:1166532-1166642	GM12878	blood:	n/a	n/a
12	CHD2	chr20:1166464-1166869	K562	blood:	n/a	n/a
13	CREB1	chr20:1166460-1166733	A549	lung:	n/a	n/a
14	CTCF	chr20:1166500-1166650	GM06990	blood:	n/a	chr20:1166567-1166585
15	CTCF	chr20:1166560-1166710	GM12872	blood:	n/a	chr20:1166567-1166585
16	CTCF	chr20:1166500-1166650	HMEC	breast:	n/a	chr20:1166567-1166585
17	CTCF	chr20:1166466-1166742	SK-N-SH_RA	brain:	n/a	chr20:1166567-1166585
18	CTCF	chr20:1166501-1166664	GM20000	blood:	n/a	chr20:1166567-1166585
19	CTCF	chr20:1166540-1166690	GM12878	blood:	n/a	chr20:1166567-1166585
20	CTCF	chr20:1166540-1166690	GM12869	blood:	n/a	chr20:1166567-1166585
21	CTCF	chr20:1167056-1167078	GM10248	blood:	n/a	n/a
22	CTCF	chr20:1166450-1166685	LNCaP	prostate:	n/a	chr20:1166567-1166585
23	CTCF	chr20:1166467-1166670	SK-N-SH_RA	brain:	n/a	chr20:1166567-1166585
24	CTCF	chr20:1166860-1167010	HRPEpiC	eye:	n/a	n/a
25	CTCF	chr20:1166500-1166650	NHEK	skin:	n/a	chr20:1166567-1166585
26	CTCF	chr20:1166500-1166650	NHLF	lung:	n/a	chr20:1166567-1166585
27	CTCF	chr20:1166520-1166670	GM12870	blood:	n/a	chr20:1166567-1166585
28	CTCF	chr20:1166500-1166650	HEK293	kidney:	n/a	chr20:1166567-1166585
29	CTCF	chr20:1166520-1166670	HRE	kidney:	n/a	chr20:1166567-1166585
30	CTCF	chr20:1166407-1166779	K562	blood:	n/a	chr20:1166567-1166585
31	CTCF	chr20:1166355-1166907	HCT-116	colon:	n/a	chr20:1166567-1166585
32	CTCF	chr20:1166500-1166650	GM12874	blood:	n/a	chr20:1166567-1166585
33	CTCF	chr20:1166455-1166727	GM13977	blood:	n/a	chr20:1166567-1166585
34	CTCF	chr20:1166460-1166610	RPTEC	kidney:	n/a	chr20:1166567-1166585
35	CTCF	chr20:1166560-1166710	HPAF	blood vessel:	n/a	chr20:1166567-1166585
36	CTCF	chr20:1166540-1166690	GM12866	blood:	n/a	chr20:1166567-1166585
37	CTCF	chr20:1166220-1166370	GM12869	blood:	n/a	n/a
38	CTCF	chr20:1166500-1166650	HepG2	liver:	n/a	chr20:1166567-1166585
39	CTCF	chr20:1166460-1166610	GM12868	blood:	n/a	chr20:1166567-1166585
40	CTCF	chr20:1166500-1166650	Hela-S3	cervix:	n/a	chr20:1166567-1166585
41	CTCF	chr20:1166466-1166735	GM19239	blood:	n/a	chr20:1166567-1166585
42	CTCF	chr20:1166520-1166670	GM12872	blood:	n/a	chr20:1166567-1166585
43	CTCF	chr20:1166446-1166737	GM19240	blood:	n/a	chr20:1166567-1166585
44	CTCF	chr20:1166520-1166670	HUVEC	blood vessel:	n/a	chr20:1166567-1166585
45	CTCF	chr20:1166500-1166650	GM12864	blood:	n/a	chr20:1166567-1166585
46	CTCF	chr20:1166940-1167090	HBMEC	blood vessel:	n/a	n/a
47	CTCF	chr20:1166465-1166713	MCF-7	breast:	n/a	chr20:1166567-1166585
48	CTCF	chr20:1166540-1166690	GM12868	blood:	n/a	chr20:1166567-1166585
49	CTCF	chr20:1166500-1166650	AG04449	skin:	n/a	chr20:1166567-1166585
50	CTCF	chr20:1166500-1166650	HL-60	blood:	n/a	chr20:1166567-1166585

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:1166329-1166379	BJ	skin:	n/a
2	chr20:1166481-1166531	GM12878	blood:	n/a
3	chr20:1166481-1166531	HCT-116	colon:	n/a
4	chr20:1166481-1166531	HCM	heart:	n/a
5	chr20:1166329-1166379	NT2-D1	testis:	n/a
6	chr20:1166481-1166531	PFSK-1	brain:	n/a
7	chr20:1166329-1166379	T-47D	breast:	n/a
8	chr20:1165703-1165753	HAEpiC	amniotic membrane:	n/a
9	chr20:1166329-1166379	U87	brain:	n/a
10	chr20:1166481-1166531	BJ	skin:	n/a
11	chr20:1165703-1165753	HIPEpiC	eye:	n/a
12	chr20:1165703-1165753	ECC-1	luminal epithelium:	n/a
13	chr20:1166481-1166531	SKMC	muscle:	n/a
14	chr20:1165703-1165753	PFSK-1	brain:	n/a
15	chr20:1166329-1166379	Hepatocyte	liver:	n/a
16	chr20:1166481-1166531	A549	lung:	n/a
17	chr20:1166481-1166531	NHBE	bronchial:	n/a
18	chr20:1166481-1166531	HIPEpiC	eye:	n/a
19	chr20:1165703-1165753	GM06990	blood:	n/a
20	chr20:1166329-1166379	AG09309	skin:	n/a
21	chr20:1166329-1166379	SK-N-MC	brain:	n/a
22	chr20:1166481-1166531	T-47D	breast:	n/a
23	chr20:1166481-1166531	HEK293	kidney:	embryo
24	chr20:1166329-1166379	SAEC	small airway:	n/a
25	chr20:1166329-1166379	NH-A	brain:	n/a
26	chr20:1165703-1165753	HMEC	breast:	n/a
27	chr20:1166329-1166379	AG04449	skin:	fetal
28	chr20:1166329-1166379	LNCaP	prostate:	n/a
29	chr20:1166329-1166379	HRCEpiC	kidney:	n/a
30	chr20:1166481-1166531	HAEpiC	amniotic membrane:	n/a
31	chr20:1166329-1166379	HCM	heart:	n/a
32	chr20:1166329-1166379	PANC-1	pancreas:	n/a
33	chr20:1166329-1166379	K562	blood:	n/a
34	chr20:1166329-1166379	HIPEpiC	eye:	n/a
35	chr20:1166329-1166379	MCF10A-Er-Src	breast:	n/a
36	chr20:1165703-1165753	SKMC	muscle:	n/a
37	chr20:1166481-1166531	NH-A	brain:	n/a
38	chr20:1166481-1166531	GM12891	blood:	n/a
39	chr20:1166329-1166379	RPTEC	kidney:	n/a
40	chr20:1166329-1166379	HCF	heart:	n/a
41	chr20:1165703-1165753	PrEC	prostate:	n/a
42	chr20:1165703-1165753	GM12891	blood:	n/a
43	chr20:1165703-1165753	HNPCEpiC	eye:	n/a
44	chr20:1166329-1166379	HepG2	liver:	n/a
45	chr20:1166481-1166531	AG09319	gingival:	n/a
46	chr20:1165703-1165753	HUVEC	blood vessel:	n/a
47	chr20:1165703-1165753	RPTEC	kidney:	n/a
48	chr20:1166481-1166531	SK-N-SH_RA	brain:	n/a
49	chr20:1166481-1166531	GM06990	blood:	n/a
50	chr20:1166481-1166531	Hela-S3	cervix:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr20:1166329..1168074-chr20:1189249..1191383,2	K562	blood:
2	chr20:796367..797247-chr20:1166167..1167087,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM74B-2	chr20:1165782-1166059	NONHSAT078092

Variant related genes	Relation type
TMEM74B	TF binding region
TMEM74B	CpG island

Extended variants
information (count: 52 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:52 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs560786346	chr20:1165864-1165865	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
2	rs190365650	chr20:1165884-1165885	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs550087496	chr20:1165894-1165895	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs13041890	chr20:1165928-1165929	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs13040743	chr20:1165939-1165940	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs13040745	chr20:1165946-1165947	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs909880	chr20:1166037-1166038	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs528797289	chr20:1166091-1166092	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs182242287	chr20:1166131-1166132	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs547996936	chr20:1166133-1166134	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs571811628	chr20:1166142-1166143	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs191955920	chr20:1166164-1166165	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs184064587	chr20:1166174-1166175	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs551071295	chr20:1166192-1166193	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs567738116	chr20:1166220-1166221	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs536724555	chr20:1166295-1166296	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs188211208	chr20:1166448-1166449	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs573265461	chr20:1166463-1166464	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs193170118	chr20:1166465-1166466	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs558525029	chr20:1166516-1166517	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs575411830	chr20:1166530-1166531	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs74272318	chr20:1166533-1166534	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs545787030	chr20:1166538-1166539	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs574226425	chr20:1166539-1166540	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs539928743	chr20:1166542-1166543	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs559761978	chr20:1166543-1166544	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs531932378	chr20:1166557-1166558	Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs149518635	chr20:1166601-1166602	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs552057516	chr20:1166622-1166623	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs565408473	chr20:1166623-1166624	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs531159849	chr20:1166637-1166638	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs550924226	chr20:1166680-1166681	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs567845895	chr20:1166691-1166692	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs183875352	chr20:1166694-1166695	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs547113996	chr20:1166736-1166737	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs566875345	chr20:1166786-1166787	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs538615600	chr20:1166841-1166842	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs75601580	chr20:1166893-1166894	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs3827158	chr20:1166912-1166913	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs75642605	chr20:1166919-1166920	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs531603851	chr20:1166946-1166947	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs574287720	chr20:1166957-1166958	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs539942252	chr20:1166985-1166986	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs553407571	chr20:1167066-1167067	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs186921085	chr20:1167076-1167077	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs548425347	chr20:1167091-1167092	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs545455852	chr20:1167103-1167104	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs372420404	chr20:1167179-1167180	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs562423777	chr20:1167190-1167191	Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs375446234	chr20:1167200-1167201	Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Glioblastoma multiforme	22286061	CNVD
Hepatocellular carcinoma	22174799	CNVD
Colorectal cancer	19455253	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17603634	CNVD
Colorectal cancer	19359472	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16774939	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16397240	CNVD
abortions and stillbirths	19751515	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	17363583	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:272 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:1164800-1166800	Active TSS	Pancreatic Islets	Pancreatic Islet
2	chr20:1165000-1166000	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr20:1165000-1166200	Bivalent/Poised TSS	Adipose Nuclei	Adipose
4	chr20:1165000-1166200	Active TSS	Brain Anterior Caudate	brain
5	chr20:1165000-1166800	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr20:1165000-1166800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
7	chr20:1165000-1166800	Bivalent/Poised TSS	Fetal Brain Female	brain
8	chr20:1165000-1167000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
9	chr20:1165200-1165800	Bivalent/Poised TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr20:1165200-1165800	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
11	chr20:1165200-1165800	Bivalent Enhancer	Fetal Brain Male	brain
12	chr20:1165200-1166000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr20:1165200-1166000	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
14	chr20:1165200-1166000	Enhancers	Gastric	stomach
15	chr20:1165200-1166000	Flanking Active TSS	Lung	lung
16	chr20:1165200-1166000	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
17	chr20:1165200-1166000	Flanking Active TSS	Right Ventricle	heart
18	chr20:1165200-1166400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
19	chr20:1165200-1166600	Active TSS	Left Ventricle	heart
20	chr20:1165200-1166600	Active TSS	Right Atrium	heart
21	chr20:1165200-1166600	Active TSS	K562	blood
22	chr20:1165200-1166800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
23	chr20:1165200-1166800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
24	chr20:1165400-1165800	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr20:1165400-1165800	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr20:1165400-1165800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
27	chr20:1165400-1165800	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
28	chr20:1165400-1165800	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
29	chr20:1165400-1165800	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
30	chr20:1165400-1165800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr20:1165400-1165800	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
32	chr20:1165400-1165800	Active TSS	Ovary	ovary
33	chr20:1165400-1165800	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
34	chr20:1165400-1166000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
35	chr20:1165400-1166000	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr20:1165400-1166000	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell
37	chr20:1165400-1166000	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr20:1165400-1166000	Flanking Active TSS	Primary hematopoietic stem cells	blood
39	chr20:1165400-1166000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr20:1165400-1166000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr20:1165400-1166000	Bivalent/Poised TSS	Psoas Muscle	Psoas
42	chr20:1165400-1166200	Bivalent Enhancer	Spleen	Spleen
43	chr20:1165400-1166400	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr20:1165400-1166400	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr20:1165400-1166400	Bivalent/Poised TSS	HMEC	breast
46	chr20:1165400-1166600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr20:1165400-1166600	Active TSS	A549	lung
48	chr20:1165400-1166800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
49	chr20:1165600-1165800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
50	chr20:1165600-1165800	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links